Dr. Esther Gillen, MSN, APRN, FNP-C
What this data tells you about Dr. Gillen
Dr. Esther Gillen is a nurse practitioner - family in Granbury, TX, with 4 years in practice. Based on federal Medicare data, Dr. Gillen performed 10,686 Medicare services across 3,612 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gillen received a total of $1,739 from 29 pharmaceutical and/or device companies across 52 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gillen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,100 | $19 | $67 |
| Blood draw (venipuncture) | 1,591 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,450 | $8 | $36 |
| Comprehensive metabolic blood panel | 906 | $10 | $64 |
| Office visit, established patient (30-39 min) | 777 | $76 | $368 |
| Flow cytometry, additional marker | 528 | $19 | $180 |
| Office visit, established patient (20-29 min) | 525 | $50 | $250 |
| Magnesium level test | 349 | $7 | $29 |
| Lactate dehydrogenase (enzyme) level | 321 | $6 | $31 |
| Ferritin level test (iron stores) | 306 | $13 | $60 |
| Iron level test | 305 | $6 | $27 |
| Iron binding capacity test | 305 | $9 | $35 |
| Vitamin B-12 level test | 188 | $15 | $76 |
| Immunoglobulin level test | 171 | $9 | $56 |
| Microscopic examination for white blood cells with manual cell count | 115 | $4 | $22 |
| Complete blood count (CBC), automated | 115 | $6 | $34 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 108 | $4 | $33 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 66 | $39 | $313 |
| Measurement of immunoglobulin light chains | 64 | $17 | $60 |
| Office visit, established patient, complex (40-54 min) | 59 | $114 | $496 |
| Beta-2 microglobulin (protein) level | 56 | $16 | $96 |
| Carcinoembryonic antigen (cea) protein level | 56 | $19 | $99 |
| Basic metabolic blood panel | 54 | $8 | $49 |
| PSA test (prostate cancer screening) | 42 | $18 | $94 |
| Irrigation of implanted venous access drug delivery device | 41 | $14 | $114 |
| Drug injection, under skin or into muscle | 38 | $9 | $96 |
| Folic acid level test | 27 | $14 | $73 |
| Flow cytometry technique for dna or cell analysis, first marker | 23 | $59 | $298 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gillen is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 18%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gillen experienced with denosumab injection (prolia/xgeva)?
Does Dr. Gillen receive payments from pharmaceutical companies?
How do Dr. Gillen's costs compare to other nurse practitioner - familys in Granbury?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology